Commentary: “Despite many years of experience taking care of heart patients, I, too, went into denial when I first felt chest ...

A patient who, despite risk factors or comorbidities, can get on a treadmill faces low mortality risk. But the reverse is ...

KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) (TSXV: KWE) ("KWESST" or the "Company"), today announced that it has ...

GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F 18) injection, for coronary artery disease ...

Coronary artery disease occurs when plaque builds up, restricting blood flow, and requires immediate treatment with ...

Managing director outlines what brought the Canadian dollar to this point and how advisors can use it to their clients' ...

Global Net Lease has underperformed risk-free Treasuries since its IPO while taking on incredible levels of leverage. We now ...

Coronary artery disease is the most common type of heart disease in the United States, according to the Centers for Disease Control and Prevention.

GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...

People who can exercise sufficiently on a treadmill during cardiac stress testing have a lower mortality risk regardless of ...

Learn the essential facts about systolic heart failure affecting 6.5 million Americans. Recognize warning signs and ...